tumor necrosis factor

tumor necrosis factor
Name	Tumor necrosis factor
Uniprot	P01375
Organism	Homo sapiens

tumor necrosis factor is a proinflammatory cytokine central to innate immunity, cell death, and systemic inflammation. It was first characterized for its ability to induce necrosis in certain tumors and has since been implicated in diverse processes including sepsis, autoimmunity, and cancer biology. TNF functions through receptors to engage apoptotic, necroptotic, and survival signaling cascades and is a major therapeutic target across rheumatology, gastroenterology, and oncology.

Overview

TNF was discovered in studies involving William B. Coley, Isaac Adler, Ludwik Hirszfeld, Paul Ehrlich, Niels Jerne, and other early immunologists exploring tumor regression, and later biochemical purification by laboratories associated with Frederick W. St. George, Anthony Cerami, Bruce Beutler, and Bert Vogelstein. It is produced primarily by activated macrophages, linked historically to research at institutions such as the National Institutes of Health and Harvard Medical School, and has been the subject of landmark clinical trials at centers including Mayo Clinic and Massachusetts General Hospital. Discoveries about TNF informed awards like the Nobel Prize in Physiology or Medicine for cytokine biology and influenced drug development pathways at companies such as Genentech, AbbVie, Janssen, Pfizer, and Eli Lilly.

Structure and Isoforms

The TNF gene encodes a type II transmembrane protein processed by ADAM17 to release a soluble form; structural insights were advanced using techniques developed at institutions like Cold Spring Harbor Laboratory, Max Planck Institute, and European Molecular Biology Laboratory. X-ray crystallography and cryo-EM studies by groups at MRC Laboratory of Molecular Biology, Stanford University, and University of Cambridge revealed a homologous trimeric fold related to the tumor necrosis factor superfamily members characterized by researchers at Memorial Sloan Kettering Cancer Center, Johns Hopkins University, and Scripps Research. Isoforms include membrane-bound TNF and soluble TNF with differential receptor affinities for TNFR1 and TNFR2; comparative genomics involving The Wellcome Trust Sanger Institute and Broad Institute has mapped TNF homologs across species studied at facilities like Smithsonian Institution and Kew Gardens.

Biological Functions and Signaling Pathways

TNF engages receptors to activate canonical pathways first delineated in landmark work at Cold Spring Harbor Laboratory and Rockefeller University, including NF-κB, MAP kinase, and caspase cascades. Signal transduction studies involving collaborators at Yale University, University of Oxford, and Karolinska Institutet linked TNF to transcriptional programs regulating cytokines, chemokines, and adhesion molecules investigated by teams at Imperial College London and University of California, San Francisco. TNF modulates apoptosis via caspase-8, necroptosis via RIPK1/RIPK3/MLKL complexes identified in labs at Dana-Farber Cancer Institute and University of Texas MD Anderson Cancer Center, and can influence cellular proliferation pathways studied at Columbia University and University College London.

Role in Disease and Pathophysiology

Pathological TNF activity underlies chronic inflammatory diseases characterized in cohort studies at Cleveland Clinic, Karolinska Hospital, and Guy's and St Thomas' NHS Foundation Trust, including rheumatoid arthritis, inflammatory bowel disease, and psoriasis—conditions central to clinical trials at University of Pennsylvania and Vanderbilt University Medical Center. In sepsis and acute inflammatory syndromes documented by investigators at Johns Hopkins Hospital and Mount Sinai Hospital, TNF contributes to vascular leak and shock. TNF's roles in cancer microenvironments, cachexia, and metabolic dysregulation were explored in translational programs at MD Anderson, University of Chicago, and Fred Hutchinson Cancer Center.

Therapeutic Targeting and Clinical Applications

Neutralization of TNF revolutionized treatment of autoimmune disease through biologics developed by firms like AbbVie (adalimumab), Johnson & Johnson subsidiaries (infliximab), and Amgen; pivotal trials were coordinated with clinical networks at NIH Clinical Center and Oxford University Hospitals. Small molecules, receptor fusion proteins, and monoclonal antibodies targeting TNF or its receptors have been evaluated in randomized trials under regulatory review by agencies such as Food and Drug Administration and European Medicines Agency. Anti-TNF therapy impacts infectious risk profiles studied in registries maintained by British Society for Rheumatology, American College of Rheumatology, and European League Against Rheumatism and informed vaccination guidelines from organizations like Centers for Disease Control and Prevention.

Regulation and Expression

Transcriptional and post-transcriptional control of TNF involves transcription factors characterized by labs at Institut Pasteur, Max Planck Institute, and University of Tokyo; mRNA stability and translation are modulated by RNA-binding proteins and microRNAs explored at EMBL-EBI and Cold Spring Harbor Laboratory. Epigenetic regulation and promoter polymorphisms were mapped through consortia such as 1000 Genomes Project, International HapMap Project, and ENCODE Project with clinical correlations reported by research groups at Mount Sinai, University of Helsinki, and Imperial College London.

Experimental Methods and Research Models

Experimental interrogation of TNF utilizes animal models developed at Jackson Laboratory and MRC Harwell, in vitro systems from core facilities at Broad Institute and Weizmann Institute of Science, and high-throughput assays established at Sanger Institute and Swiss Institute of Bioinformatics. Techniques include ELISA, flow cytometry, single-cell RNA-seq, and CRISPR screens pioneered at Broad Institute and MIT; translational studies leverage biobanks and cohorts from UK Biobank, Framingham Heart Study, and international consortia such as Human Cell Atlas.

Category:Cytokines